Immediate Impact
41 standout
Citing Papers
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
2022 Standout
Cisplatin in cancer treatment
2022 Standout
Works of John A. Prior being referenced
Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
1985
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| John A. Prior | 103 | 28 | 1 | 53 | 50 | 8 | 182 | |
| L. Champion | 93 | 57 | 25 | 51 | 9 | 248 | ||
| Mohamad S. Sandid | 140 | 115 | 37 | 33 | 6 | 254 | ||
| Ayah El‐Fahmawi | 34 | 44 | 119 | 31 | 10 | 262 | ||
| Florian Desgranges | 37 | 31 | 51 | 29 | 11 | 166 | ||
| Fengyao Wu | 133 | 129 | 1 | 43 | 24 | 12 | 253 | |
| Guy Choshen | 42 | 51 | 35 | 26 | 8 | 141 | ||
| Marnie J. Wood | 71 | 7 | 18 | 8 | 9 | 261 | ||
| David M. Simon | 155 | 55 | 2 | 41 | 34 | 8 | 279 | |
| Jenna Allard | 42 | 66 | 38 | 19 | 6 | 281 | ||
| Rachael Almond | 80 | 12 | 29 | 21 | 9 | 157 |
All Works
Loading papers...